Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL4225966 (Sel-120 free base) |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| casein kinase 1 alpha 1/Casein kinase I isoform alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2793] [GtoPdb: 1995] [UniProtKB: P48729] | ||||||||
| ChEMBL | Inhibition of CSNK1A1 (unknown origin) by ADP-Glo assay | B | 5.86 | pIC50 | 1390 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
| casein kinase 2, alpha prime polypeptide subunit/Casein kinase II subunit alpha` in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4070] [GtoPdb: 1550] [UniProtKB: P19784] | ||||||||
| ChEMBL | Inhibition of CSNK2A2 (unknown origin) by ADP-Glo assay | B | 6.55 | pIC50 | 278.9 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
| cyclin dependent kinase 2/CDK2/Cyclin A2 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL3038469] [GtoPdb: 1973] [UniProtKB: P20248, P24941] | ||||||||
| ChEMBL | Inhibition of CDK2/cyclinA2 (unknown origin) by ADP-Glo chemiluminescence assay | B | 8.33 | pIC50 | 4.7 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
| cyclin dependent kinase 7/CDK7/Cyclin H/MNAT1 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL3038473] [GtoPdb: 1979] [UniProtKB: P50613, P51946, P51948] | ||||||||
| ChEMBL | Inhibition of CDK7/cyclinH/MAT1 (unknown origin) by ADP-Glo chemiluminescence assay | B | 7.29 | pIC50 | 50.97 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
| cyclin dependent kinase 8/CDK8/Cyclin C in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL3038474] [GtoPdb: 1980] [UniProtKB: P24863, P49336] | ||||||||
| GtoPdb | Binding dissociation constant for hCDK8 protein | - | 8.52 | pKd | 3 | nM | Kd | Oncotarget (2017) 8: 33779-33795 [PMID:28422713] |
| ChEMBL | Inhibition of CDK8/CyclinC (unknown origin) by ADP-Glo chemiluminescence assay | B | 7.76 | pIC50 | 17.5 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
| ChEMBL | Inhibition of His tagged human recombinant CDK8/Cyclin C expressed in baculovirus expression system incubated for 15 mins by FRET-based LanthaScreen binding competition assay | B | 7.85 | pIC50 | 14.11 | nM | IC50 | J Med Chem (2023) 66: 5439-5452 [PMID:37029334] |
| ChEMBL | Displacement of tracer 236 from CDK8/cyclin C (unknown origin) preincubated for 15 mins followed by tracer addition and measured after 60 mins by FRET based lanthascreen assay | B | 7.85 | pIC50 | 14.1 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
| ChEMBL | Inhibition of CDK8/Cyclin C (unknown origin) | B | 8.36 | pIC50 | 4.4 | nM | IC50 | J Med Chem (2022) 65: 6390-6418 [PMID:35485642] |
| ChEMBL | Inhibition of CDK8/CyclinC (unknown origin) incubated for 60 mins in presence of ATP by scintillation counting method | B | 8.36 | pIC50 | 4.4 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
| GtoPdb | Inhibition of CDK8/CycC kinase activity | - | 8.36 | pIC50 | 4.4 | nM | IC50 | Oncotarget (2017) 8: 33779-33795 [PMID:28422713] |
| ChEMBL | Inhibition of CDK8/Cyclin-C (unknown origin) in presence of [gamma33P]ATP by radiometric method | B | 8.4 | pIC50 | 4 | nM | IC50 | J Med Chem (2018) 61: 5073-5092 [PMID:29266937] |
| cyclin dependent kinase 19/Cyclin-C/Cyclin-dependent kinase 19 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL3883323] [GtoPdb: 1972] [UniProtKB: P24863, Q9BWU1] | ||||||||
| GtoPdb | Inhibition of CDK19/CycC kinase activity | - | 7.98 | pIC50 | 10.4 | nM | IC50 | Oncotarget (2017) 8: 33779-33795 [PMID:28422713] |
| ChEMBL | Inhibition of CDK19/Cyclin C (unknown origin) | B | 7.98 | pIC50 | 10.4 | nM | IC50 | J Med Chem (2022) 65: 6390-6418 [PMID:35485642] |
| ChEMBL | Inhibition of CDK19/Cyclin C (unknown origin) | B | 7.98 | pIC50 | 10.4 | nM | IC50 | Eur J Med Chem (2020) 203: 112571-112571 [PMID:32707525] |
| ChEMBL | Inhibition of CDK19/CyclinC (unknown origin) incubated for 60 mins in presence of ATP by scintillation counting method | B | 7.98 | pIC50 | 10.4 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
| ChEMBL | Inhibition of CDK19/Cyclin-C (unknown origin) in presence of [gamma33P]ATP by radiometric method | B | 8 | pIC50 | 10 | nM | IC50 | J Med Chem (2018) 61: 5073-5092 [PMID:29266937] |
| cyclin dependent kinase 19/Cyclin-dependent kinase 19 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6002] [GtoPdb: 1972] [UniProtKB: Q9BWU1] | ||||||||
| ChEMBL | Inhibition of CDK19 (unknown origin) by ADP-Glo assay | B | 7.6 | pIC50 | 25.1 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
| ChEMBL | Inhibition of CDK19 (unknown origin) by HTRF assay | B | 7.72 | pIC50 | 19.13 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
| GtoPdb | Inhibition of CDK19/CycC kinase activity | - | 7.98 | pIC50 | 10.4 | nM | IC50 | Oncotarget (2017) 8: 33779-33795 [PMID:28422713] |
| cyclin dependent kinase 2/Cyclin-dependent kinase 2/cyclin E1 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL1907605] [GtoPdb: 1973] [UniProtKB: P24864, P24941] | ||||||||
| ChEMBL | Inhibition of CDK2/cyclinE1 (unknown origin) by ADP-Glo chemiluminescence assay | B | 9.01 | pIC50 | 0.97 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
| cyclin dependent kinase 5/Cyclin-dependent kinase 5/CDK5 activator 1 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL1907600] [GtoPdb: 1977] [UniProtKB: Q00535, Q15078] | ||||||||
| ChEMBL | Inhibition of CDK5/p25NCK (unknown origin) by ADP-Glo chemiluminescence assay | B | 8.78 | pIC50 | 1.66 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
| ChEMBL | Inhibition of CDK5/p35NCK (unknown origin) by ADP-Glo chemiluminescence assay | B | 8.87 | pIC50 | 1.34 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
| cyclin dependent kinase 8/Cyclin-dependent kinase 8 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5719] [GtoPdb: 1980] [UniProtKB: P49336] | ||||||||
| GtoPdb | Binding dissociation constant for hCDK8 protein | - | 8.52 | pKd | 3 | nM | Kd | Oncotarget (2017) 8: 33779-33795 [PMID:28422713] |
| ChEMBL | Inhibition of CDK8 (unknown origin) in presence of ATP by ADP-Glo assay | B | 7.43 | pIC50 | 37.2 | nM | IC50 | Eur J Med Chem (2023) 251: 115214-115214 [PMID:36889252] |
| ChEMBL | Inhibition of CDK8 (unknown origin) by ADP-Glo assay | B | 7.76 | pIC50 | 17.5 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
| ChEMBL | Inhibition of CDK8 (unknown origin) by HTRF assay | B | 7.84 | pIC50 | 14.5 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
| ChEMBL | Inhibition of CDK8 (unknown origin) | B | 8.36 | pIC50 | 4.4 | nM | IC50 | Eur J Med Chem (2020) 203: 112571-112571 [PMID:32707525] |
| GtoPdb | Inhibition of CDK8/CycC kinase activity | - | 8.36 | pIC50 | 4.4 | nM | IC50 | Oncotarget (2017) 8: 33779-33795 [PMID:28422713] |
| cyclin dependent kinase 9/Cyclin-dependent kinase 9 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3116] [GtoPdb: 1981] [UniProtKB: P50750] | ||||||||
| ChEMBL | Inhibition of CDK9 (unknown origin) in presence of [gamma33P]ATP by radiometric method | B | 5.97 | pIC50 | 1070 | nM | IC50 | J Med Chem (2018) 61: 5073-5092 [PMID:29266937] |
| CDC like kinase 1/Dual specificity protein kinase CLK1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4224] [GtoPdb: 1990] [UniProtKB: P49759] | ||||||||
| ChEMBL | Inhibition of CLK1 (unknown origin) by ADP-Glo assay | B | 8.28 | pIC50 | 5.3 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
| CDC like kinase 2/Dual specificity protein kinase CLK2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4225] [GtoPdb: 1991] [UniProtKB: P49760] | ||||||||
| ChEMBL | Inhibition of CLK2 (unknown origin) by ADP-Glo assay | B | 7.68 | pIC50 | 21 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
| CDC like kinase 4/Dual specificity protein kinase CLK4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4203] [GtoPdb: 1993] [UniProtKB: Q9HAZ1] | ||||||||
| ChEMBL | Inhibition of CLK4 (unknown origin) by ADP-Glo assay | B | 8.57 | pIC50 | 2.7 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
| dual specificity tyrosine phosphorylation regulated kinase 1A/Dual specificity tyrosine-phosphorylation-regulated kinase 1A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2292] [GtoPdb: 2009] [UniProtKB: Q13627] | ||||||||
| ChEMBL | Inhibition of DYRK1A (unknown origin) by ADP-Glo assay | B | 6.48 | pIC50 | 332.2 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
| homeodomain interacting protein kinase 3/Homeodomain-interacting protein kinase 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4577] [GtoPdb: 2035] [UniProtKB: Q9H422] | ||||||||
| ChEMBL | Inhibition of HIPK3 (unknown origin) by ADP-Glo assay | B | 6.88 | pIC50 | 131.8 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
| mitogen-activated protein kinase 15/Mitogen-activated protein kinase 15 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5198] [GtoPdb: 2090] [UniProtKB: Q8TD08] | ||||||||
| ChEMBL | Inhibition of ERK8 (unknown origin) by ADP-Glo assay | B | 5.87 | pIC50 | 1344 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
| Rho associated coiled-coil containing protein kinase 1/Rho-associated protein kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3231] [GtoPdb: 1503] [UniProtKB: Q13464] | ||||||||
| ChEMBL | Inhibition of ROCK1 (unknown origin) by ADP-Glo assay | B | 6.14 | pIC50 | 717.5 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
| histone H3 associated protein kinase/Serine/threonine-protein kinase haspin in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075163] [GtoPdb: 2028] [UniProtKB: Q8TF76] | ||||||||
| ChEMBL | Inhibition of HASPIN (unknown origin) by ADP-Glo assay | B | 7.34 | pIC50 | 46 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
| Pim-2 proto-oncogene, serine/threonine kinase/Serine/threonine-protein kinase pim-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4523] [GtoPdb: 2159] [UniProtKB: Q9P1W9] | ||||||||
| ChEMBL | Inhibition of PIM2 (unknown origin) by ADP-Glo assay | B | 6.53 | pIC50 | 298.2 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
| TAO kinase 1/Serine/threonine-protein kinase TAO1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5261] [GtoPdb: 2233] [UniProtKB: Q7L7X3] | ||||||||
| ChEMBL | Inhibition of TAOK1 (unknown origin) by ADP-Glo assay | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2024) 67: 8161-8171 [PMID:38690856] |
ChEMBL data shown on this page come from version 36:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]